Praesidian Capital Europe Successfully Exits Medical Laboratory Group
LONDON — August 17, 2021 — Praesidian Capital Europe (“Praesidian”), a leading private capital investor announced today it has successfully exited its investment in Laboratory Dr. Schumacher MVZ GmbH, a regional medical laboratory business based in Bremerhaven, Germany. Praesidian invested in the business in 2015 and the laboratory has experienced significant growth to become a leading regional operator…